Hanmi Pharm. Co., Ltd. (128940.KS) on Thursday reported higher first-quarter profit, while revenue was broadly stable.
Net income from continuing operation before income tax rose to 55.380 billion won from 53.177 billion won in the same period last year.
Operating income declined to 53.649 billion won from 59.020 billion won a year earlier.
Net income attributable to shareholders of the parent company increased to 45.490 billion won from 42.606 billion won in the prior-year period.
Sales were 392.926 billion won, 0.5% up from 390.948 billion won a year earlier.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.